Jazz Pharmaceuticals (JAZZ) Free Cash Flow (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Free Cash Flow of $331.0 million for Q1 2026, down 22.99% year-over-year from $429.8 million in Q1 2025, and down 71.51% quarter-over-quarter from $1.2 billion in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Free Cash Flow (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Free Cash Flow history runs 17 years deep, the most recent figure standing at $331.0 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 22.99% year-over-year to $331.0 million; the TTM figure through Mar 2026 stood at $1.2 billion (down 21.4% YoY), while the FY2025 annual figure was $1.3 billion, down 4.48% from the prior year.
- Free Cash Flow for Q1 2026 stood at $331.0 million, down from $1.2 billion in the prior quarter.
- The five-year high for Free Cash Flow was $1.2 billion in Q4 2025, with the low at -$382.6 million in Q3 2025.
- The 5-year median for Free Cash Flow is $316.9 million (2023), against an average of $313.3 million.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow soared 629.43% in 2022, then plunged 198.63% in 2025.
- Jazz Pharmaceuticals' Free Cash Flow stood at $337.6 million in 2022, then plunged by 46.33% to $181.2 million in 2023, then jumped by 112.64% to $385.3 million in 2024, then surged by 201.54% to $1.2 billion in 2025, then tumbled by 71.51% to $331.0 million in 2026.
- Business Quant data shows JAZZ's Free Cash Flow at $331.0 million in Q1 2026, $1.2 billion in Q4 2025, and -$382.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | 415.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 415.70 Mn |
| Jun 30, 2026 | 415.70 Mn |
| Mar 31, 2026 | 331.00 Mn |
| Mar 31, 2026 | 331.00 Mn |
| Dec 31, 2025 | 1.16 Bn |
| Dec 31, 2025 | 1.16 Bn |
| Sep 30, 2025 | -382.64 Mn |
| Sep 30, 2025 | -382.64 Mn |
| Jun 30, 2025 | 88.04 Mn |
| Jun 30, 2025 | 88.04 Mn |
| Mar 31, 2025 | 429.80 Mn |
| Mar 31, 2025 | 429.80 Mn |
| Dec 31, 2024 | 385.29 Mn |
| Dec 31, 2024 | 385.29 Mn |
| Sep 30, 2024 | 387.96 Mn |
| Sep 30, 2024 | 387.96 Mn |
| Jun 30, 2024 | 321.45 Mn |
| Jun 30, 2024 | 321.45 Mn |
| Mar 31, 2024 | 263.14 Mn |
| Mar 31, 2024 | 263.14 Mn |